MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.5080
+0.0230
+4.74%
After Hours: 0.5096 +0.0016 +0.32% 19:55 02/06 EST
OPEN
0.5109
PREV CLOSE
0.4850
HIGH
0.5269
LOW
0.4851
VOLUME
802.93K
TURNOVER
--
52 WEEK HIGH
1.800
52 WEEK LOW
0.3067
MARKET CAP
29.71M
P/E (TTM)
-0.7057
1D
5D
1M
3M
1Y
5Y
1D
Femasys enters distribution partnership with OR Consulting
TipRanks · 4d ago
Femasys Partners With OR Consulting Over Commercial Rollout Of Product Portfolio In Switzerland
Benzinga · 4d ago
Femasys Expands into Switzerland with OR Consulting for Women's Health Products
Reuters · 4d ago
Femasys Inc. Signs Swiss Distribution Agreement for FemBloc and FemaSeed
Reuters · 4d ago
Femasys Expands European Commercial Footprint with Swiss Partner for FemBloc, FemaSeed, and Portfolio Products
Barchart · 4d ago
Weekly Report: what happened at FEMY last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at FEMY last week (0119-0123)?
Weekly Report · 01/26 09:27
After-Hours Gainers: ATOS, IBRX, FEMY, FHTX, DARE, TBPH
NASDAQ · 01/20 04:19
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.